Complete Patient Support Programs logo
  • Important Safety Information
    Full Prescribing Information
    RINVOQ® / RINVOQ® LQ
    Important Safety Information,
    including BOXED WARNING

    Full Prescribing Information
    SKYRIZI®
    Important Safety Information
    Full Prescribing Information
  • <Variable Practice Name> Account Menu
    <Variable Practice Name>
    <Variable User Name>
    Settings Log Out
Complete Pro
Continue
RINVOQ upadacitinib and RINVOQ LQ logo
SKYRIZI risankizumab-rzaa logo

Click for RINVOQ/RINVOQ LQ Important Safety Information, including BOXED WARNING on Serious Infections, Mortality, Malignancies, Major Adverse Cardiovascular Events, and Thrombosis.

Click for SKYRIZI Important Safety Information.

Full prescribing information for RINVOQ/RINVOQ LQ, and SKYRIZI.

Privacy Notice | Cookie Settings | Your Privacy Choices

US-MULT-260229 | ©AbbVie 2026 | Contact Us | Accessibility Statement

Contact Us

Technical Support

877-COMPLETE (877-266-7538) Option 3

(Monday through Friday from 7:00 A.M. to 7:00 P.M. Central Time)

AbbVie Access Support

877-COMPLETE (877-266-7538) Option 2

(Monday through Friday from 7:00 A.M. to 7:00 P.M. Central Time)

myAbbVie Assist Patient Assistance

Phone: 800-222-6885

Fax: 866-250-2803

Customer Solutions Specialist

Field Reimbursement Manager

Back

US-MULT-260229